Accendra Health Names Kenneth Gardner-Smith As New CEO
(RTTNews) - Accendra Health, Inc. (ACH), a healthcare company, on Thursday said it named Kenneth Gardner-Smith as its new President and Chief Executive Officer, effective early in the fourth quarter of 2026.
Accendra Health has appointed Kenneth Gardner-Smith as their next CEO, effective early in the fourth quarter of 2026. Gardner-Smith has been a member of the company's Board of Directors since March 2022 and will replace Edward A. Pesicka, who has announced his retirement plans. Gardner-Smith currently leads Veritas Veterinary Partners and previously held operating roles at DaVita for 13 years, overseeing $1.5 billion in operations.
Mark Beck, Chair of Accendra Health's Board of Directors, expressed confidence in Gardner-Smith's ability to lead the company, given his extensive experience in reimbursement-driven healthcare. Pesicka will continue in his role until Gardner-Smith assumes the position and will act as an advisor during the transition. Scott Lloyd has also been appointed as Chief Commercial Officer, starting on October 5, 2026.
Lloyd will be responsible for overseeing commercial strategy, sales, and provider and payor partnerships. He previously co-founded Extrakare LLC and served as Chief Development and Strategy Officer at Evergreen Nephrology.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Accendra Health names Kenneth Gardner-Smith as next CEO investing.com
